Gain Therapeutics, Inc. (GANX)

Gain Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	12.05	11.79	7.31	36.88	7.49	0.3
Short-Term Investments	-	5	12.83	-	-	-
Cash & Short-Term Investments	12.05	16.79	20.14	36.88	7.49	0.3
Cash Growth	-1.50%	-16.60%	-45.40%	392.21%	2370.30%	-24.30%
Accounts Receivable	-	-	-	-	0.01	-
Other Receivables	0.37	0.24	0.19	0.2	0.06	0.04
Receivables	0.37	0.24	0.19	0.2	0.07	0.04
Prepaid Expenses	1.32	0.74	0.76	0.65	0.2	-
Restricted Cash	-	-	-	-	0.01	-
Other Current Assets	-	-	-	-	1.22	0.08
Total Current Assets	13.74	17.78	21.09	37.72	8.99	0.43
Property, Plant & Equipment	0.4	0.59	0.8	1.01	0.55	0.22
Long-Term Investments	-	-	1.94	-	-	-
Other Intangible Assets	0.16	0.19	0.21	0.2	-	-
Other Long-Term Assets	0.07	0.05	0.05	0.05	0.06	0.01
Total Assets	14.37	18.61	24.1	38.99	9.6	0.66
Accounts Payable	1.1	1.32	1.63	0.56	0.96	0.15
Accrued Expenses	-	2.11	2	1.4	0.76	0.25
Current Portion of Long-Term Debt	0.12	0.12	0.11	0.1	0.02	-
Current Portion of Leases	0.18	0.23	0.23	0.22	0.12	0.1
Current Income Taxes Payable	-	0.05	0.11	0	0	0
Current Unearned Revenue	0.71	1.12	0.06	0.27	0.24	0.37
Other Current Liabilities	2.49	-	-	-	0.01	-
Total Current Liabilities	4.59	4.95	4.13	2.55	2.11	0.88
Long-Term Debt	0.38	0.45	0.5	0.59	0.72	-
Long-Term Leases	0.1	0.23	0.44	0.7	0.4	0.1
Long-Term Unearned Revenue	0.07	0.09	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	5.46	6.03	5.22	4.17	3.4	1.11
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	86.09	73.11	57.36	55.83	13.39	3.09
Retained Earnings	-77.43	-60.78	-38.52	-20.93	-7.03	-3.46
Comprehensive Income & Other	0.24	0.25	0.04	-0.09	-0.15	-0.08
Total Common Equity	8.91	12.58	18.88	34.82	6.2	-0.45
Shareholders' Equity	8.91	12.58	18.88	34.82	6.2	-0.45
Total Liabilities & Equity	14.37	18.61	24.1	38.99	9.6	0.66
Total Debt	0.77	1.03	1.27	1.61	1.26	0.2
Net Cash (Debt)	11.28	15.77	20.81	35.27	6.23	0.1
Net Cash Growth	0.77%	-24.22%	-41.01%	466.03%	5987.28%	-
Net Cash Per Share	0.57	1.21	1.75	3.47	2.32	0.05
Filing Date Shares Outstanding	26.53	16.22	11.88	11.88	4.02	2.25
Total Common Shares Outstanding	25.96	16.21	11.88	11.88	4.02	2.25
Working Capital	9.15	12.83	16.97	35.17	6.87	-0.45
Book Value Per Share	0.34	0.78	1.59	2.93	1.54	-0.20
Tangible Book Value	8.75	12.38	18.67	34.61	6.2	-0.45
Tangible Book Value Per Share	0.34	0.76	1.57	2.91	1.54	-0.20
Machinery	-	0.18	0.17	0.12	0.03	0.01
Leasehold Improvements	-	0.03	0.03	0.02	0.01	0.01

Source: S&P Capital IQ. Standard template. Financial Sources.